2018 Faculty

Roberto Aguirre, MD, CPI, CCRP
VP, Global Research Director & Co-Founder
AGA Clinical Trials

Dr. Roberto Aguirre is a certified Principal Investigator, VP, Global Research Director, and Co-Founder of AGA Clinical Trials (Miami, FL) and AGA Clinical (Ecuador), both multi-specialty Phase I-IV Research Centers. He is also a doctor of medicine and surgery in Ecuador and has been involved in over 183 trials since 2005. He spent time as a Clinical Research Coordinator at the University of Miami, Miller School of Medicine from 2005-2006, and CRSF since 2006-2007. Dr. Aguirre has also spent the last 22 + years volunteering as a Diabetes Senior Instructor at the FUNDACION ASISTENCIA DIABETOLOGICA ECUATORIANA where he helps to educate, treat patients and teenagers on how to manage their diabetes diagnosis including; carbohydrate counting, insulin management therapy, as well as psychological support for patients and families after the initial diagnosis. He has a passion and specialty in Clinical Operations and International Business Development.

Todd Albin, MBA, CCRP
Senior Director, Site Enrollment Optimization
Acurian, USA

Todd Albin, MBA, CCRP is an experienced clinical research professional who has worked in the late phase site environment for 18 years. He has worked as a study coordinator, site manager/director and regional manager for research sites and site management organizations in Florida, California and Arizona. Todd was also an adjunct faculty instructor for Pima Community College’s Clinical Research Coordinator program where he developed curriculum and taught classes on clinical research site coordination and management, ethics and diversity in clinical research. In 2014, he joined the Global Patient Recruitment and Retention company, Acurian, where he is the Senior Director of Site Enrollment Optimization. Todd is a Certified Clinical Research Professional and received his bachelor’s degree in business from the University of Miami and his Master’s in Business Administration from Florida International University.


Valdo Arnera
General Manager Geneva Office & Scientific Advisor
ERT, Switzerland

A Medical Doctor by training, Valdo has over 30 years of experience in the pharmaceutical industry. After having practiced medicine in various positions, he started his career in the industry as a clinical pharmacologist in a Ciba-Geigy’s daughter company. He then founded the first European Central Clinical Laboratory dedicated to clinical trials, SciCor (now Covance Central Laboratory) in 1992. After that, he joined PHT in 2000, and founded its European affiliate in January 2001. PHT was acquired by ERT in May 2015. Skilled in both science and management, Dr. Arnera currently serves as the General Manager of ERT eCOA European operations. He has also been very involved with DIA and was the co-chair of the DIA 2011 Euromeeting. Valdo's goals are to improve the way clinical trials are performed and, more generally, the way healthcare is delivered.


Scott Askin
Digital Development Director
Novartis, Switzerland

Having been working in the Pharma industry for over 15 years, Scott Askin is digital strategist, intrapeneur and a self-proclaimed master of Data Management. Based in Basel Switzerland, he is a member of the Novartis Digital elite and leads the company’s work in the area of electronic Source (eSource) and electronic Informed Consent (eICF/eConsent). Spending the first years of his career working within a CRO and later moving into Pharma, Scott spent the majority of his working life in Data Management, later moving into Data Standards and more recently into the ever evolving and exciting world that is Digital. Scott has a proven track record of demonstrated success, in taking on and overcoming the “impossible” and bringing new technologies to fruition through identifying, testing and bringing solutions to scale, in close collaboration with internal and external stakeholders. Scott has a BSc (Hons) in Computing and Management Sciences from Sheffield Hallam University in the United Kingdom.


Wendy Baird
Senior Director, Contracts & Compliance
MeDiNova Research, UK

 

Andrew Benzie, MD
Head of Patients in Partnerships
GlaxoSmithKline

During the drug development process, I work with patient advocacy groups in a variety of ways. For example, 12 years ago, GSK founded a Focus on the Patient seminar series, which brings patients to GSK sites during the drug development process. Through this program, employees have the opportunity to hear directly from patients, caregivers, and advocates and to close knowledge gaps with the multidimensional aspects of the disease, from its clinical course to its effects on daily life and personal experiences. With one particular oncology medicine, patient voices helped us streamline the clinical trial design of a Phase 2 study so that it was less burdensome and more relevant to patients. Additionally, in September 2016, the Patients in Partnership team was established, bringing enterprise leadership in establishing patient influence to GSK decision making, from early R&D through to marketed products. The team drives the process and business culture changes needed to increase patient involvement throughout the business and across the medicine lifecycle, reflecting the company’s renewed commitment to ensuring patients are truly at the center of its work.


Jonca Bull, MD
Vice President, Regulatory Consulting; Ophthalmology Therapeutic Area Director
PPD, USA

Dr. Jonca Bull returned to FDA in August 2012 as the Director of the Office of Minority Healthfter most recently serving as Vice President for US Drug Regulatory Policy at Novartis and, prior to that, as Director of Clinical Regulatory Policy at Genentech. Dr. Bull previously served in FDA in a variety of positions in both the Center for Drug Evaluation and Research (CDER) and the Office of the Commissioner spanning 12 years. Dr. Bull also previously spent eleven years providing clinical care in a multi-specialty group practice, and she currently serves as an Assistant Clinical Professor at George Washington University Medical Center. Dr. Bull is a graduate of Princeton University and received her medical degree from Duke University School of Medicine. She did her postgraduate training at George Washington University, is board certified in Ophthalmology, and is a fellow of the American Academy of Ophthalmology.


Mark. A. Campbell
Vice President, International Programme Management
Synexus, UK

Mark Campbell is a seasoned programme and project management leader, with rich and diverse experience in both early stage and global, world class life science organisations. Mark manages the International Project Management team accountable for delivering our international clinical trial program. He has over 16 years’ life sciences experience and holds a BSc (Hons) and M.Sc. in Strategic Project Management from Leeds University where he is a also a guest lecturer. Prior to joining Synexus, Mark held a number of senior leadership and consulting positions for leading and emerging biotech/pharma companies, such as, Amgen, Fresenius Biotech, Quanticate and Johnson and Johnson.


Matt Cooper
Business Development & Marketing Director
NIHR, UK

Dr. Matt Cooper is Business Development and Marketing Director for the National Institute for Health Research (NIHR) Clinical Research Network. Previously he led the Network’s Cancer Specialty and prior to that has held clinical research roles within AstraZeneca UK, an NHS Foundation Trust and Leeds Institute of Molecular Medicine.


Ian Dalton
Senior Director, Finance
IQVIA, UK

 

Nikki Dewick
Director of Clinical Site Management, UK Cluster
Pfizer, UK & Ireland

Nikki holds an honours degree in Human Biology. She started her Clinical Research career in 1994 as a CRA with Sandoz. She then joined Pharmacia/Pfizer, maintaining a variety of roles throughout the Clinical Research spectrum culminating in her most recent position as Director of Clinical Site Management for UK/Ireland.


Diane Driver
Head Outsourcing Contracts & Strategic Partnerships
UCB, UK

Diane started her career as a pharmacologist at Smith Kline & French, before switching to Clinical Development in a CRO in 1988. She then spent 12 years taking roles of increasing responsibility and geographical scope, before moving to Pharma in 2000. During her time at UCB she has led global clinical development programs, set up and managed a global in-house monitoring team, as well as spending 3 years outside clinical operations in the strategic role of Global Project Leader leading global cross-functional teams to develop new drug candidates from research to clinical POC. In 2014 she returned to Clinical Operations to head up UCB’s Outsourcing Contracts & Strategic Partnering department, where she is responsible for developing and implementing the global clinical outsourcing strategy and the management /oversight of UCB’s Strategic Partnering relationships. In addition, Diane also represents UCB on the Oversight Committee of TransCelerate.


Paul Duffy
Director Clinical Research UK & Ireland
MSD, UK

Paul is a registered General Nurse with a Post Graduate Diploma’s in Medical Ethics and Law and also Medical Research, Biotechnology and Law. Paul joined the pharmaceutical industry following an eight-year career in Accident and Emergency nursing. His clinical experience includes working in a variety of global pharmaceutical and Clinical Research Organisations and small biotechnology companies, including European, USA, and Japanese managed organisations. He joined Schering Plough as Clinical Research Manager UK from Sosei Company, where he had worked as European Clinical Director for 3 years. In 2008 he was appointed Head of Clinical Operations, UK & ROI and was appointed Clinical Research Director for UK & ROI at MSD in January 2010.


Marie Emms
Head, Global Clinical Trial Engagement
INC Research/InVentiv Health, USA

Marie Emms has 20 years of experience in healthcare communications, spanning PR, medical education and clinical trial recruitment support. She has spent the past 15 years focused solely in patient recruitment, supporting pharma, biotech and CRO clients. She specializes in the development and execution of strategic integrated communications programs to support sites and their patients through the clinical trial journey, from initial awareness, consent through to compliance and adherence. Marie has worked on a wide variety of therapeutic areas across neonatal, pediatric, adult and geriatric studies.


David Fauvart, PMP
Associate Director - Clinical Innovation
The Janssen Pharmaceutical Companies of Johnson & Johnson, Belgium

 

Agnieszka Gackowska
Senior Director, Site Alliance, Global Head
PAREXEL, Poland

Agnieszka Gackowska graduated from the Medical Academy in Warsaw in 1995. She worked in the Department of Internal Medicine and CSK MSW Cardiology Department in Warsaw. Since 1997 until 2009 associated with the pharmaceutical industry, as the Product Manager of GlaxoSmithKline's vaccine products, and then as the Head of Marketing and Sales of Institutional Products for hormone replacement therapy and haemostatic drugs in Novo Nordisk. She was a contributor of campaigns that built awareness of patients about diseases, treatment and prevention. She was the co-founder and Managing Director of Haemophilia Foundation in Poland in 2006-2009 and the Association for Treatment of Severe Bleeding Disorders and the originator and leader of the international School of Menopause for doctors 2003-2008. Since August 2009 till the end of 2014, she was responsible for Site Management Department on position of Director of East Europe & Middle East in Quintiles CRO. In 2015 she was promoted on the Senior Director position responsible for cooperation with Sites & Patients networks in Central Eastern Europe and Middle East with special focus on new model of creation and management of clinical trials – patients and sites centric approach. In July 2016 she joined PAREXEL International CRO as the Global Head of Site Alliance Program to lead a group of dedicated managers who manage the relationships and support the development of selected research institutions. Her interests are focused on effective methods of communication between doctors, patients and representatives of pharmaceutical business, including those currently supporting the decision to participate in clinical trials and to develop a standard model of conducting clinical research centre. Global Star Award Winner of 2002 GlaxoSmithKline, Novo Nodisk Best Affiliate Performance 2003, "Success of the Year 2005" organized by the publisher for an educational program Termedia for School Menopause.


Almenia Garvey, MSc
Director, Health Care Alliances
Clinical Research Service
ICON plc, France

Almenia Garvey is the Director of Site Alliances at ICON plc. ICON is a full service CRO that offers a range of services to assist the pharmaceutical, biotech and medical device industries in bringing new products to market. Almenia has over 20 years of experience in Minority recruitment, site selection strategy, investigator identification and investigator relationship management.


Andrew Gebbie
Principal Solution Consultant
Medidata Solutions, UK

 

Steven Geller, MD
Medical Director
Centennial Medical Group, an RxTrials site, USA

Steven Geller MD FACP CPI graduated from the Johns Hopkins University School of Medicine in 1985 , and then completed his internal medicine residency at the Johns Hopkins Hospital. Since then he has been in private practice at Centennial Medical Group, where he is currently the Medical Director. He is also a Past President of the Medical Staff at Howard County General Hospital , and a past member of the executive committee of the board of trustees for the Johns Hopkins Medical Institutions. He has been performing clinical research for about 14 years and has been an investigator in approximately 85 studies. He has been a past member of the CPI examination committee for the American College of Research Professionals (ACRP) and a past member of the Leadership Council of the Society of Clinical Research Sites (SCRS).



Martin Gibson, MD, PhD, MB ChB, FRCP
Chief Executive Officer
Northwest EHealth, UK

Martin Gibson serves as Clinical Director at the NIHR Clinical Research Network for Greater Manchester, Associate Director for Industry (Clinical Research Networks), Chief Executive Officer at Northwest EHealth, and as a Consultant Physician (Diabetes and Endocrinology) for the Salford Royal NHS Foundation Trust.

His areas of interest include:
• The processes by which insulin resistance and glucose intolerance predispose individuals to vascular disease focusing on the role of the insulin-like growth factor (IGF) system.
• The development novel interventions across primary and secondary care to measure and optimise vascular risk reduction utilizing district-wide electronic patient information systems to target and monitor intervention programmes. This includes the ongoing development of a proactive contact-centre based diabetes management and prevention systems.
•Use of electronic clinical information systems to support improved healthcare and clinical research including the development of large scale 'real world' studies.

Dr. Gibson's specialties include Diabetes, Lipid Disorders, Clinical Trials, Clinical Data Systems, and Patient Self-Management.


Gretchen Goller
Global Head of Patient Recruitment
ICON plc, USA

Gretchen leads the Patient Recruitment Services group at ICON working with a team of strategists to implement recruitment and retention programs on all pertinent ICON studies. Most recently Gretchen was the Senior Director leading the Patient Access and Retention Services group at PRA for 5+ years. Prior to that she was the Patient Recruitment and Retention Strategist at Sanofi-Aventis.


Clare Grace, PhD
Vice President, Site & Patient Access
INC Research/inVentiv Health, UK

Clare brings nearly two decades of strategic global leadership expertise to her role, including a unique blend of academic, pharmaceutical, biotech and CRO industry experience. She joined INC Research from PPD where she held several senior leadership roles, including most recently Senior Direct and Head of Global Site Intelligence. Clare holds a PhD in Molecular Oncology from the University of Manchester Institute of Science and Technology and a bachelor’s degree in applied biochemistry from Liverpool John Moores University.


Eric Klaver
GCP & QA Trainer
Amsterdam Clinical Research Academy, The Netherlands

Eric brings vast experience in both clinical research and Clinical Research Training. Eric has trained from the United States to China, from Mexico to Australia, from Brazil to Korea, from Israel to Malawi, the Gabon and Kenya and all over the European continent. Eric is currently the trainer of choice for the Free University (VU) Amsterdam, responsible for their clinical research module of their acclaimed masters programme.


Emil Kostov, MPharm
Site Alliance & Support Manager
COMAC Medical Ltd, Bulgaria

More than 5 years in Clinical Research, currently Head of the Site Alliance Network in Comac Medical Ltd, consisting of more than 200 PIs and more than 90 Institutions in 12 countries in Central and Eastern Europe.
Main responsibilities: Site Alliance Network set up and expansion, Supervision of all aspects of Site Support activities; Guaranteeing smooth process of recruitment potential assessment and site selection proposal, as well as during the study conduct; Supervision of all employees within the group.


Rudi Ladenius
Regional Site Advocate
Vertex Pharmaceuticals, The Netherlands

 

Lorraine Large
Associate Director, Central Monitoring, EAPA, Adaptive Monitoring Leadership Team
PRA Health Sciences, UK

 

Andrew Masih
Senior Director, Clinical Operations
Medpace, UK

 

Dan Milam
Vice President of Global Engagement
Society for Clinical Research Sites, USA

Dan Milam is the vice president of Global Engagement for the Society for Clinical Research Sites (SCRS). With over twenty years of experience working in the pharmaceutical, CRO, and site sectors, Dan has an intimate understanding of the needs of the industry as a whole and is adept at facilitating and building strong alliances. His focus is on expanding SCRS’ global footprint and the inclusion of all industry stakeholders in SCRS initiatives with the goal to foster sustainability for clinical research sites.


Paulo Moreiro
Vice President, Global Clinical Operations - External Innovation
EMD Serono, USA

Paulo is a Clinical Development executive with 25+ years of experience in Clinical R&D. He has been with EMD Serono for the last 17 years in diverse positions within Clinical Development, and he presently serves as the Head of Global Clinical Operations External Innovation. In this capacity, Paulo is responsible for Clinical Innovation as well for Patient Centricity in Clinical Development and Operations where he has had a preponderant role in establishing EMD Serono as an industry leader in patient centricity around clinical trials. Paulo is also a Visiting Scholar at Boston College where he teaches at the Essentials of Clinical Research and Project Management Program. Paulo is very active in several industry-wide organizations. He dedicates some of his time to the Steering Committee of the Clinical Trial Transformation Initiative (CTTI). He leads TransCelerate’s Clinical Research Awareness & Access workstream and represents EMD Serono on TransCelerate’s Operations Committee and fulfills the role as the Global Impact Partner of the Society for Clinical Research Sites (SCRS). Paulo also serves on the Advisory Board of a couple of companies that provide services to the Pharma/Biotech industries. Lastly, Paulo was named twice to PharmaVoice’s 100 Most Inspirational Leaders of 2015 and 2017 recognizing his industry leadership around patient centricity.


Sergii Myronenko, MD
CEO
PharmaSich, Ukraine

Dr. Myronenko is a clinical research professional with astrong medical background: board certified anesthesiologist and four and a half years of experience as an ICU physician. He has 13 years of experience within the clinical research industry in various roles (QA, PM, Medical Reviewer, Start Up, Business Development). Dr. Myronenko is a key founder and CEO of PharmaSich CRO. His professional interests include clinical trials in Eastern Europe and models of the collaboration between niche CROs.


Kate O'Brien
Senior Research Nurse
Albany House Medical Centre, UK

Kate O'Brien has worked in Primary Care research since 1999. Her practice practice conducts phase 2-4 industry trials, plus academic studies and has been awarded leadership site status for the second year for the East Midlands South Yorkshire Research Network. Kate's role includes assessing trial feasibility, liaising with Sponsors and co-ordinating all trial requirements, plus the daily management of studies covering a wide range of conditions.


Brendan O'Neill
Sr. Director Patient Recruitment
Pfizer, UK

 

Christine Pierre
President
Society for Clinical Research Sites, USA

Christine Pierre is the President of the Society for Clinical Research Sites (SCRS). She is internationally known for her expertise in clinical research site management and patient recruitment and retention for the clinical trials industry. In addition, she also addresses audiences around the world on issues pertaining to human subject protection, site operations and subject recruitment and retention. Her global reach has included presentations in Australia, Canada, Africa, Israel, and the United States.


Sheuli Porkess, MD
Interim Executive Director Research, Medical & Innovation
The Association of the British Pharmaceutical Industry, UK

Sheuli Porkess is an experienced Medical Affairs Physician, who is currently the Interim Executive Director of Research, Medical & Innovation at the Association of the British Pharmaceutical Industry. Sheuli’s career began in clinical medicine in the NHS and subsequently has included a number of medical leadership roles at a national, regional and international level, including Medical Director roles in the Netherlands, Nordics and UK. Sheuli was the Global Head of Quality Management for Medicine and Regulatory, for Boehringer Ingelheim in Germany. Sheuli is Director of a medical affairs consultancy, Actaros and the MedicoMarketing Partnership. Sheuli is a Fellow of the Faculty of Pharmaceutical Medicine in the UK and is on the Board of Examiners for the Faculty.


Irina Ringler
Senior Director, Site Intelligence, Site Centricity Unit
INC Research/inVentiv Health, Germany

Irina brings over 15 years of experience in clinical Research & Development, with a focus on study planning and site identification. She is currently Director of Feasibility & Clinical Informatics at inVentiv Health Clinical. Most recently, Irina served as Director of Feasibility at RPS where she was responsible for the set up and operation of a dedicated global feasibility group. Irina began her industry career as a CRA with GE Healthcare, spent 5 years in a feasibility management role at ICON and worked at Imclone Systems, an Eli Lilly company. She is a graduate of LMU Munich in Germany, with a Master of Science degree in Biology.


Claire Sears, PhD
Director, Data Solutions
DrugDev, UK

Claire Sears joined DrugDev in 2013. She leads DrugDev’s communications and training activities for the TransCelerate Investigator Registry and the Investigator Databank, and also leads DrugDev’s thought leadership program for Data Solutions. Claire earned her BA(Hons) and her Doctorate in Cardiovascular Physiology from the University of Oxford.


Helena Sigal, MD
Founder & Owner
SIGAL Site Management & Support, Germany

Helena Sigal, MD started her professional carrier as a medical doctor and investigator. Growing very fast in the clinical research field, she has overtaken the positions of Director Clinical Operations or Head of Operations Germany with the International Dedicated Research Centers Company. After years of experience, she decided to set up her own company - SMO in Germany - to support the sites to become more professional.


Matt Simmons
Independent Consultant
UK

With extensive operational and commercial experience across all phases of drug development within the Pharmaceutical and CRO industries, Matt has overall responsibility for the day-to-day management of the Sarah Cannon Research UK Drug Development Unit. Matt received his degree in Molecular Biology from The University of Manchester in 1994 and joined what was then SmithKline Beecham working on the clinical development of a novel cytotoxic agent. Immediately before joining Sarah Cannon Research Institute UK he managed the global Commercial Operations teams for Worldwide Clinical Trials, a mid-sized, full service CRO.


Craig Stevenson
Area Head Western Europe
Pfizer, UK

Craig is an experienced clinical research professional with over a 25 years of experience. He has international experience across a variety of clinical research roles and has led clinical research teams both in the UK and abroad (e.g., China). In his current role, he is responsible for Pfizer’s Clinical Research Operations in over 25 countries (including Eastern Europe, Africa, and the Middle East).


Wojciech Szczepanik, PhD, MBA, MSc
Managing Director, Central Europe
Synexus, Poland

Wojciech started his adventure with drug development choosing the Biomedicinal Chemistry department at the University of Wroclaw as his PhD studies location. After completing the PhD degree he joined AstraZeneca where he learned the rules and regulations around the clinical trials as a CRA and later as a Local Study Delivery Team Leader. In 2009 he joined Synexus as a Site Manager, where he developed his expertise in the business by managing the Dedicated Research Site. He later became a Director of Operations taking the responsibility for all the Synexus sites in Poland. He developed the network in Poland and was further given the role of the regional Managing Director of the Central Europe where he expands the Synexus Business in Poland, Hungary and recently Italy.


Jane Trim
Country Clinical Quality Manager
MSD, UK

 

Vivienne van de Walle, MD, PhD, CPI
Director & Owner
PT&R, The Netherlands

Vivienne van de Walle studied medicine at the University of Maastricht in the Netherlands and did part of her medical training at the University of Oxford in the UK. During her medical training she enjoyed the combination of patient care and clinical research. She received an additional medical science degree for her research in OBGYN, pediatrics and genetics when she graduated. In 2004 she successfully defended her thesis on Auxology for her PhD. She has always combined clinical research with patient care and has been a full time investigator since 1999 at independent clinical research sites. Vivienne co-founded and has co-owned PT&R since 2006 and took over fully in 2013. In 2011, she passed the CPI exam. A member of the nation BROK/GCP examcie, the ACRON, APCR. SCRS and the NVFG (ClinOps Group and Fiagnostiek Magazine), she is active in social media both privately and professionally. Vivienne has been invited to teach at CROs, Pharma companies and at Universities, and she is often asked to consult for CROs and Pharma regarding protocol development, feasibilities, the Company-Site relationship, and social media. As a result, Vivienne has a unique perspective of both sides of the table in clinical research.


Tom Van Paepegem
Clinical Operations Manager
Harmony Clinical Research, Belgium

Tom received a degree as registered nurse in 1998 and a degree in medical-social sciences in 2001 from the University of Ghent. He started his career in clinical research as a trial nurse in 2002 when he joined he phase I-II unit of the University Hospital of Ghent. Subsequently he worked as quality coordinator and in a later stage he played an important role in the general management of the unit. Tom also made a significant contribution to the foundation of the Trial Bureau of the University Hospital Ghent, an internal CRO for investigator-initiated clinical research. In this role he was responsible for the operational development of the department. After a short period as Training Manager/Internal Auditor at a central laboratory, Tom joined a midsized international CRO as the Clinical Quality Assurance Auditor at the end of 2008. He was responsible on a global level for the implementation of the quality management system, for conducting internal and external audits and for providing training. As of the beginning of 2010, Tom re-oriented his career in the direction of clinical operations, more specifically to a combined role of project management / CRA and gradually he became responsible for staff recruitment as well. During his 10+ years Tom has developed a broad set of project operations experience and progressive leadership responsibility. In January 2012, together with his former colleague, Jacqueline Hertoghs, Tom co-founded the CRO Harmony Clinical Research bvba where he assumes the overall responsibility for clinical operations and staffing.


Gerda Van Wijhe
Head of Clinical Programs Early Life Nutrition
Nutricia Research, The Netherlands

 

Elizabeth Vroom
Director
Duchenne Parent Project, The Netherlands

Elizabeth Vroom is the president of the Dutch Duchenne Parent Project and the chair of the worldwide United Parent Projects Muscular Dystrophy (UPPMD). She is a member of the TREAT-NMD Project Ethics Council as well as the TACT committee and is a practising Orthodontist. Elizabeth is invited to speak at many international conferences about DMD and related issues.


Rick Ward
Vice President, Commercial Operations
Trifecta Clinical, USA

Rick Ward is Vice President of Commercial Operations at Trifecta - a leading global clinical technology solutions provider, producing more than 350 live, on-demand and web-based Investigator meetings each year in 87 countries. Prior to joining Trifecta, Rick has driven commercial growth strategies and led business development efforts for various CRO and niche service organizations supporting the Clinical Trial industry. Rick has over 20 years of business development experience, in both direct sales and sales management roles. Rick graduated with a degree in Marketing from the Pennsylvania State University and is a member of the Hammond Society, having served on Penn State’s Smeal College of Business Alumni Society Board of Directors from 1999 through 2013. Rick is also one of the founding members and former President of the Smeal Business Club of Philadelphia.